BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29982797)

  • 1. Surfactant protein-D, a potential mediator of inflammation in axial spondyloarthritis.
    Munk HL; Fakih D; Christiansen L; Tan Q; Christensen AF; Ejstrup L; Loft AG; Junker K; Kyvik KO; Jounblat R; Holmskov U; Sorensen GL; Junker P
    Rheumatology (Oxford); 2018 Oct; 57(10):1861-1865. PubMed ID: 29982797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant protein D multimerization and gene polymorphism in COPD and asthma.
    Fakih D; Akiki Z; Junker K; Medlej-Hashim M; Waked M; Salameh P; Holmskov U; Bouharoun-Tayoun H; Chamat S; Sorensen GL; Jounblat R
    Respirology; 2018 Mar; 23(3):298-305. PubMed ID: 28960651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating surfactant protein -D is low and correlates negatively with systemic inflammation in early, untreated rheumatoid arthritis.
    Christensen AF; Sørensen GL; Hørslev-Petersen K; Holmskov U; Lindegaard HM; Junker K; Hetland ML; Stengaard-Pedersen K; Jacobsen S; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Tarp U; Pødenphant J; Vestergaard A; Jurik AG; Østergaard M; Junker P
    Arthritis Res Ther; 2010; 12(2):R39. PubMed ID: 20211020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating surfactant protein D is decreased in systemic lupus erythematosus.
    Hoegh SV; Voss A; Sorensen GL; Høj A; Bendixen C; Junker P; Holmskov U
    J Rheumatol; 2009 Nov; 36(11):2449-53. PubMed ID: 19833760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
    Glintborg B; Sørensen IJ; Østergaard M; Dreyer L; Mohamoud AA; Krogh NS; Hendricks O; Andersen LS; Raun JL; Kowalski MR; Danielsen L; Pelck R; Nordin H; Pedersen JK; Kraus DG; Christensen SR; Hansen IM; Esbesen J; Schlemmer A; Loft AG; Al Chaer N; Salomonsen L; Hetland ML
    J Rheumatol; 2017 Jan; 44(1):59-69. PubMed ID: 27909080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B27 prevalence in axial spondyloarthritis patients and in blood donors in a Lebanese population: Results from a nationwide study.
    Ziade N; Abi Karam G; Merheb G; Mallak I; Irani L; Alam E; Messaykeh J; Menassa J; Mroue' K; Uthman I; Masri AF; Ghorra P; Witte T; Baraliakos X
    Int J Rheum Dis; 2019 Apr; 22(4):708-714. PubMed ID: 30729696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts.
    Ez-Zaitouni Z; Hilkens A; Gossec L; Berg IJ; Landewé R; Ramonda R; Dougados M; van der Heijde D; van Gaalen F
    Arthritis Res Ther; 2017 May; 19(1):118. PubMed ID: 28569222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of HLA-B15 and HLA-B27 in spondyloarthritis with peripheral and axial clinical patterns.
    Londono J; Santos AM; Peña P; Calvo E; Espinosa LR; Reveille JD; Vargas-Alarcon G; Jaramillo CA; Valle-Oñate R; Avila M; Romero C; Medina JF
    BMJ Open; 2015 Nov; 5(11):e009092. PubMed ID: 26560062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
    Levitova A; Hulejova H; Spiritovic M; Pavelka K; Senolt L; Husakova M
    Arthritis Res Ther; 2016 Nov; 18(1):275. PubMed ID: 27887637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis.
    Olesen HV; Holmskov U; Schiøtz PO; Sørensen GL
    J Cyst Fibros; 2010 Jul; 9(4):257-62. PubMed ID: 20457545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.
    Micheroli R; Hebeisen M; Wildi LM; Exer P; Tamborrini G; Bernhard J; Möller B; Zufferey P; Nissen MJ; Scherer A; Ciurea A;
    Arthritis Res Ther; 2017 Jul; 19(1):164. PubMed ID: 28724442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and environmental influences of surfactant protein D serum levels.
    Sørensen GL; Hjelmborg Jv; Kyvik KO; Fenger M; Høj A; Bendixen C; Sørensen TI; Holmskov U
    Am J Physiol Lung Cell Mol Physiol; 2006 May; 290(5):L1010-7. PubMed ID: 16361352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiopathogenic role of surfactant protein d in the clinical and immunological expression of primary Sjögren syndrome.
    Soto-Cárdenas MJ; Gandía M; Brito-Zerón P; Arias MT; Armiger N; Bové A; Bosch X; Retamozo S; Akasbi M; Pérez-De-Lis M; Gueitasi H; Kostov B; Pérez-Alvarez R; Siso-Almirall A; Lozano F; Ramos-Casals M
    J Rheumatol; 2015 Jan; 42(1):111-8. PubMed ID: 25362659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating surfactant protein D is decreased in early rheumatoid arthritis: a 1-year prospective study.
    Hoegh SV; Lindegaard HM; Sorensen GL; Høj A; Bendixen C; Junker P; Holmskov U
    Scand J Immunol; 2008 Jan; 67(1):71-6. PubMed ID: 18052966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of bone morphogenic protein 2 and interleukin-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study.
    Perrotta FM; Scriffignano S; Lubrano E
    Clin Exp Rheumatol; 2019; 37(6):1044-1047. PubMed ID: 31376251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of surfactant protein D gene polymorphism with susceptibility to gestational diabetes mellitus: a case-control study.
    Xu J; Chen Y; Tang L; Teng X; Feng L; Jin L; Wang G; Wang L
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):231. PubMed ID: 35317741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of H- and L-ficolin are increased in axial spondyloarthritis: improvement of disease identification.
    Troldborg A; Thiel S; Mistegaard CE; Hansen A; Korsholm TL; Stengaard-Pedersen K; Loft AG
    Clin Exp Immunol; 2020 Jan; 199(1):79-87. PubMed ID: 31518441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD74 IgA autoantibodies in radiographic axial spondyloarthritis: a longitudinal Swedish study.
    Do L; Granåsen G; Hellman U; Lejon K; Geijer M; Baraliakos X; Witte T; Forsblad-d'Elia H
    Rheumatology (Oxford); 2021 Sep; 60(9):4085-4093. PubMed ID: 33369649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma concentration of surfactant protein D in chronic periodontitis independent of SFTPD genotype: potential role as a biomarker.
    Glas J; Beynon V; Bachstein B; Steckenbiller J; Manolis V; Euba A; Müller-Myhsok B; Folwaczny M
    Tissue Antigens; 2008 Jul; 72(1):21-8. PubMed ID: 18498293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.